CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project focuses on enhancing the effectiveness of cancer treatments by engineering nanoparticles and natural signaling carriers called extracellular vesicles. It aims to improve the targeting of these therapies to metastatic tissues by understanding the biological factors that influence their behavior in the body.
Metastasis research is one of the greatest challenges in the medical field.
The nanoengineering of inorganic/organic nanoparticles (NPs) with natural signaling carriers such as extracellular vesicles (EVs) is a promising tool to address the lack of treatment efficiency of currently available therapies, blamed on the insufficient accumulation of the antitumoral molecules in the metastasis tissues.
Despite several years of intense efforts, therapeutic EVs are still far away from clinical practice.…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
